{
    "Trade/Device Name(s)": [
        "Duo-Max Blood Pressure and Glucose Monitor",
        "Blood Pressure and Glucose Monitor, Duo-Max",
        "Model HMF-100"
    ],
    "Submitter Information": "HuBDiC Co., Ltd.",
    "510(k) Number": "K080636",
    "Predicate Device Reference 510(k) Number(s)": [
        "K052108",
        "K051285"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JJX",
        "DXN"
    ],
    "Summary Letter Date": "January 30, 2009",
    "Summary Letter Received Date": "February 2, 2009",
    "Submission Date": "January 11, 2008",
    "Regulation Number(s)": [
        "21CFR862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine",
        "misc"
    ],
    "Analyte(s)": [
        "Glucose",
        "Systolic blood pressure",
        "Diastolic blood pressure",
        "Pulse rate"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Duo-Max Blood Pressure and Glucose Monitor",
        "Model HMF-100"
    ],
    "Method(s)/Technology(ies)": [
        "Glucose oxidase",
        "Oscillometric method"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Test Strip",
        "Quality Control Material",
        "Meter",
        "Cuff"
    ],
    "Document Summary": "FDA 510(k) summary for Duo-Max Blood Pressure and Glucose Monitor Model HMF-100 for quantitative glucose and blood pressure measurement in home and clinical settings",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in capillary whole blood from multiple body sites and for measuring systolic and diastolic blood pressure and pulse rate from adult's wrist in home and clinical environments; not for neonatal use or diabetes diagnosis/screening",
    "fda_folder": "Clinical Chemistry"
}